Asaleo Care Limited revised earnings guidance for the year ended December 31, 2017. For the period the company expects Underlying EBITDA will be in the range of AUD 124 million to AUD 125 million compared with previous guidance of low single digit growth. Underlying NPAT will be in the range of AUD 59 million to AUD 60 million compared with previous guidance of low single digit growth. Statutory NPAT will be in the range of AUD 57 million to AUD 58 million. Underlying EPS will be in the range of 10.8 cents per share to 11.0 cents per share compared with previous guidance of low to mid-single digit growth. Free cash flow will be in the range of AUD 70 million to AUD 75 million compared with previous guidance of AUD 85 million to AUD 95 million.